Top News
'Exercise Pill' ENV-308 Clears First Human Trial
Enveda's experimental pill ENV-308, designed to mimic an exercise-linked molecule, passed a Phase I safety trial in 88 healthy adults.
MarketsIndicesCommoditiesFXRates
